source
- Vertex to acquire endocrinology startup Crinetics for $10 billion, signaling push into new therapeutic areasVertex Pharmaceuticals announced a $10 billion cash purchase of Crinetics, an endocrinology-focused biotech. The deal represents the largest acquisition in Vertex’s history and underscores its pla…
- Vera Therapeutics receives accelerated approval for Trutakna to treat IgA nephropathyVera Therapeutics announced that its fusion protein atacicept, branded as Trutakna, has been granted accelerated approval by the FDA for the treatment of immunoglobulin A nephropathy, a chronic aut…